MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/eja.0000000000001459

Медицинская библиотека · European journal of anaesthesiology · 2021

National outcomes and characteristics of patients admitted to Swedish intensive care units for COVID-19: A registry-based cohort study.

Chew Michelle S, Blixt Patrik Johansson, Åhman Rasmus, Engerström Lars, Andersson Henrik, Berggren Ritva Kiiski, Tegnell Anders, McIntyre Sarah

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Mortality among patients admitted to intensive care units (ICUs) with COVID-19 is unclear due to variable follow-up periods. Few nationwide data are available to compare risk factors, treatment and outcomes of COVID-19 patients after ICU admission.

OBJECTIVE

To evaluate baseline characteristics, treatments and 30-day outcomes of patients admitted to Swedish ICUs with COVID-19.

DESIGN

Registry-based cohort study with prospective data collection.

SETTING

Admissions to Swedish ICUs from 6 March to 6 May 2020 with laboratory confirmed COVID-19 disease.

PARTICIPANTS

Adult patients admitted to Swedish ICUs.

EXPOSURES: Baseline characteristics, intensive care treatments and organ failures.

MAIN OUTCOMES AND MEASURES: The primary outcome was 30-day all-cause mortality. A multivariable model was used to determine the independent association between potential predictor variables and death.

RESULTS

We identified 1563 patients with complete 30-day follow-up. The 30-day all-cause mortality was 26.7%. Median age was 61 [52 to 69], Simplified Acute Physiology Score III (SAPS III) was 53 [46 to 59] and 62.5% had at least one comorbidity. Median PaO2/FiO2 on admission was 97.5 [75.0 to 140.6] mmHg, 74.7% suffered from moderate-to-severe acute respiratory failure. Age, male sex [adjusted odds ratio (aOR) 1.5 (1.1 to 2.2)], SAPS III score [aOR 1.3 (1.2 to 1.4)], severe respiratory failure [aOR 3.0 (2.0 to 4.7)], specific COVID-19 pharmacotherapy [aOR 1.4 (1.0 to 1.9)] and continuous renal replacement therapy [aOR 2.1 (1.5 to 3.0)] were associated with increased mortality. Except for chronic lung disease, the presence of comorbidities was not independently associated with mortality.

CONCLUSIONS

Thirty-day mortality rate in COVID-19 patients admitted to Swedish ICUs is generally lower than previously reported despite a severe degree of hypoxaemia on admission. Mortality was driven by age, baseline disease severity, the presence and degree of organ failure, rather than pre-existing comorbidities.

TRIAL REGISTRATION NO: NCT04462393.

Для цитирования: Chew Michelle S, Blixt Patrik Johansson, Åhman Rasmus, Engerström Lars, Andersson Henrik, Berggren Ritva Kiiski, Tegnell Anders, McIntyre Sarah. National outcomes and characteristics of patients admitted to Swedish intensive care units for COVID-19: A registry-based cohort study.. European journal of anaesthesiology. 2021. DOI: 10.1097/eja.0000000000001459.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.